Ali Mandegary
Impact in
- Pharmacology top 2%
Papers in
-
- Retinoids in leukemia and cellular processes 4
- Pharmacology 11
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Reza Mohammadinejad (13 shared papers)Fariba Sharififar (20 shared papers)Mohammad Amin Moosavi (3 shared papers)Marveh Rahmati (2 shared papers)Shima Tavakol (4 shared papers)Abbas Pardakhty (10 shared papers)Salik Hussain (1 shared paper)Deniz Özkan Vardar (1 shared paper)
In The Last Decade
Ali Mandegary
81 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 131
- Complementary and alternative medicine 197
- Pharmacology 177
- Biomaterials 204
- Molecular Medicine 67
- Toxicology 36
Countries citing papers authored by Ali Mandegary
This map shows the geographic impact of Ali Mandegary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Mandegary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Mandegary more than expected).
Fields of papers citing papers by Ali Mandegary
This network shows the impact of papers produced by Ali Mandegary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Mandegary. The network helps show where Ali Mandegary may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Mandegary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 347 | |
| 2 | 2018 | 237 | |
| 3 | 2012 | 107 | |
| 4 | 2006 | 86 | |
| 5 | 2017 | 85 | |
| 6 | 2019 | 71 | |
| 7 | 2019 | 71 | |
| 8 | 2016 | 52 | |
| 9 | 2012 | 49 | |
| 10 | 2019 | 49 | |
| 11 | 2018 | 48 | |
| 12 | 2005 | 48 | |
| 13 | 2013 | 46 | |
| 14 | 2020 | 41 | |
| 15 | 2006 | 41 | |
| 16 | 2016 | 41 | |
| 17 | 2020 | 39 | |
| 18 | 2018 | 39 | |
| 19 | 2016 | 34 | |
| 20 | 2018 | 31 |
About Ali Mandegary
Ali Mandegary is a scholar working on Molecular Biology, Pharmacology, Plant Science, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 85 papers that have together received 2.3k indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Heavy Metal Exposure and Toxicity (5 papers), Graphene and Nanomaterials Applications (5 papers), Retinoids in leukemia and cellular processes (4 papers), Paraquat toxicity studies and treatments (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Nanoparticles: synthesis and applications (4 papers). The work is most often cited by research in Complementary and alternative medicine (197 citations), Pharmacology (177 citations), Biomaterials (204 citations), Molecular Medicine (67 citations) and Toxicology (36 citations). Ali Mandegary has collaborated with scholars based in Iran, Singapore and Czechia. Frequent co-authors include Reza Mohammadinejad, Fariba Sharififar, Mohammad Amin Moosavi, Marveh Rahmati, Shima Tavakol, Abbas Pardakhty, Salik Hussain, Deniz Özkan Vardar, Asieh Hosseini and Daniel J. Klionsky. Their work appears in journals such as Human & Experimental Toxicology, Food and Chemical Toxicology, Toxicology and Industrial Health, Drug and Chemical Toxicology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.